Product Information
DEXTROAMP-AMPHET ER 15 MG CAP is a generic product labeled by Elite Laboratories, Inc., priced at $0.5570 per EA under NDC 64850051201. Its NADAC has been published 168 times since Jun 7, 2023.
FDA first approved this application on Dec 11, 2019. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
DEXTROAMP-AMPHET ER 15 MG CAP
Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine SulfateStrength
3.75; 3.75; 3.75; 3.75 mg/1; mg/1; mg/1; mg/1
Manufacturer
Elite Laboratories, Inc.NDC
64850051201
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATEApproval Type
Generic (ANDA)
FDA Application
ANDA212037FDA Approved
12/11/2019
TE Code
AB1
On Market Since
12/16/2019
Pharmacological Classes
Price Statistics
The NADAC for DEXTROAMP-AMPHET ER 15 MG CAP has been published 168 times since Jun 7, 2023, and over the history we have for it it has declined 20.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5570 per EA |
|---|---|
| All-time high | $0.7041 (Jun 14, 2023) |
| All-time low | $0.4362 (May 22, 2024) |
| 52-week high | $0.5766 |
| 52-week low | $0.5015 |
| Median price | $0.5932 |
| Average price | $0.5870 |
| Largest weekly change | +45.9% (Aug 21, 2024) |
| Weeks tracked | 168 |
| Tracking since | Jun 7, 2023 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 8% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of DEXTROAMP-AMPHET ER 15 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for DEXTROAMP-AMPHET ER 15 MG CAP, manufactured by Elite Laboratories, Inc., is $0.5570 per EA (NDC 64850051201), effective Aug 19, 2026.
How has the price of DEXTROAMP-AMPHET ER 15 MG CAP changed over time?
Over the history we have for it, the NADAC for DEXTROAMP-AMPHET ER 15 MG CAP has declined 20.9%. It has been tracked across 168 weekly CMS publications since Jun 7, 2023.
What are the highest and lowest recorded NADAC prices for DEXTROAMP-AMPHET ER 15 MG CAP?
Since Jun 7, 2023, the NADAC for DEXTROAMP-AMPHET ER 15 MG CAP has ranged from a low of $0.4362 (May 22, 2024) to a high of $0.7041 (Jun 14, 2023), with a median of $0.5932 per EA.
Are there cheaper alternatives to DEXTROAMP-AMPHET ER 15 MG CAP?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, DEXTROAMP-AMPHET ER 15 MG CAP, is $0.5105 per EA — about 8% below DEXTROAMP-AMPHET ER 15 MG CAP.
Who manufactures DEXTROAMP-AMPHET ER 15 MG CAP?
DEXTROAMP-AMPHET ER 15 MG CAP (NDC 64850051201) is labeled by Elite Laboratories, Inc., and CMS classifies it as a generic product.